Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Cancer|April 2, 2019
Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or…Pedro C Barata, A Oliver SartorCA: a Cancer Journal for Clinicians|September 30, 2017
Treatment of renal cell carcinoma: Current status and future directionsPedro C Barata, Brian I RiniEuropean Urology Focus|January 21, 2025
Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell CarcinomaKevin K Zarrabi, Ulka Vaishampayan, Pedro C BarataCancer Management and Research|September 20, 2019
Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamideAnita Gul, Jorge A Garcia, Pedro C BarataMedicina|December 12, 2024
Combined systemic treatments in two patients with ductal salivary carcinomaIván A Schwartz, María Laura Gil, Fernando Carrizo, et al.Journal of Kidney Cancer and VHL|July 21, 2017
The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF InhibitionPedro C Barata, Moshe C Ornstein, Jorge A GarciaClinical Genitourinary Cancer|March 31, 2026
Survival Outcomes of Cabazitaxel or Subsequent Androgen Receptor Pathway Inhibitor (ARPI) in Post-Docetaxel/ARPI Metastatic Castration-Resistant Prostate CancerPedro C Barata, Lauren Green, Christopher Kim, et al.Cancers|May 30, 2020
PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand TherapyWallace Jones, Kelly Griffiths, Pedro C Barata, et al.Therapeutic Advances in Urology|May 5, 2021
Outlook into the future of front-line immune checkpoint inhibition in metastatic urothelial carcinomaJason R Brown, Spencer Krane, Jorge Garcia, et al.Cancers|November 25, 2020
Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate CancerAlbert Jang, Oliver Sartor, Pedro C Barata, et al.Pageof 12